Accepted Abstracts 2023

List of accepted abstracts for 21st International Symposium

If your abstract title is listed below, start preparing your poster for in-person presentation at the symposium.

Make sure you and your co-author have active CRSIC membership. To avail CRSIC membership Click here.

Also, to attend the event in-person Click here to get yourself registered for the event.

Use the serial number against your abstract title from the list below as your Poster Number and print it on top right-hand-side of your poster.

Posters to be presented on Day-1 (24th Feb 2023):

1. 3D-BIOPRINTED INHERENTLY ANTIBACTERIAL CONTACT LENS CARRYING ANTIMICROBIAL PEPTIDE PAYLOAD FOR OCULAR INFECTIONS
2. 3D printing as an innovative tool to dispense personalized doses of Ondansetron hydrochloride
3. Achieving In-vivo brain delivery of antipsychotic drug through nanocomplex loaded microneedles: Evaluation for Schizophrenia
4. Affibody conjugated docetaxel NLCs: A potential active targeting nanosystem for HER2-specific cancer
5. ANALYTICAL AND BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DONEPEZIL AND FLAVANOID
6. Angiopep-2 Grafted PAMAM Dendrimers for the Targeted Delivery of Temozolomide: In-vitro and In-vivo Effects of PEGylation in the Management of Glioblastoma Multiforme
7. ANTI-VEGF LIPOSOMAL FORMULATION FOR SITE SPECIFIC DELIVERY TO TONGUE TUMOR OF RAT MODEL
8. APPLICATION OF NOVEL DRUG DELIVERY SYSTEM TO ENHANCE ANTI-ARTHRITIC ACTIVITY OF GREATER GALANGAL
9. Aptamer-tethered hyperbranched bis-MPA polyester dendrimers for targeted delivery of siRNA and gene silencing in breast cancer cells
10. Asiaticoside polymeric nanoparticles for effective diabetic wound healing: in-vitro and in-vivo evaluation
11. BACLOFEN LOADED CHITOSAN NANOPARTICLES
12. Berberine-loaded nanoparticles attenuate TGF-β-induced remodelling features in human bronchial epithelial cells
13. CAPMUL® GDB: A VERSATILE LIPID ALTERNATIVE TO A HYDROPHILIC SWELLABLE POLYMERIC MATRIX IN A SUSTAINED RELEASE TABLET
14. CAPSULE IN CAPSULE SYSTEM FOR DELIVERY OF DRUGS REQUIRING ENTERIC RELEASE
15. Chiral Curcuminands: Versatile Carriers for Combinatorial Drug Delivery System.
16. Co-delivery of anticancer drug and siRNA via nucleolin aptamer-tethered MSNPs effectively diminishes drug resistance in TNBC
17. COMPARATIVE EVALUATION OF IN-VITRO RELEASE STUDY OF LULICONAZOLE LOADED-MESOPOROUS SILICA NANOPARTICLES WITH THE MARKETED ANTIFUNGAL HYDROGEL FOR TREATMENT OF CUTANEOUS CANDIDIASIS
18. Controlled Porosity Osmotic Pump Drug Delivery Systems – Evaluation of Critical Formulation and Process Parameters on drug release kinetics from hydrodynamically induced minitablets 1
19. Curcumin loaded silica embedded Polyelectrolyte complex gel for wound healing
20. DESIGN AND DEVELOPMENT OF DISULFIRAM LOADED VAGINAL NANOCARRIER SYSTEM FOR CERVICAL CANCER
21. DESIGN AND DEVELOPMENT OF LONG-ACTING FORMULATION FOR THE TREATMENT OF POSTERIOR SEGMENT EYE DISEASES
22. DESIGN AND DEVELOPMENT OF ORODISPERSIBLE TABLETS EMPLOYING CRYSTAL ENGINEERING AND COMPUTATIONAL TOOLS
23. DESIGN AND EVALUATION OF PRONIOSOMES FOR  ANTI-ATHEROSCLEROTIC DRUG DELIVERY
24. DESIGN AND OPTIMIZATION OF ORAL METHOTREXATE MICROSPONGE FOR RHEUMATOID ARTHRITIS
25. Design of Lopinavir Loaded Nanostructured Lipid Carriers (NLCs) and Optimization of Formulation using DoE
26. DESIGN, DEVELOPMENT AND CHARACTERIZATION OF NOVEL NLC LOADED WITH PHYTOCONSTITUENT OF LIQUORICE FOR THE TREATMENT OF MELASMA.
27. DESIGN, DEVELOPMENT, AND EVALUATION OF FAST-DISSOLVING POLYMERIC MICRONEEDLE ARRAY PATCH FOR IMMEDIATE RELEASE DRUG DELIVERY
28. Development and Characterization of Methacrylated Pluronic F68- Gellan Gum Hydrogel for 3D Bioprinting
29. DEVELOPMENT AND CHARACTERIZATION OF NATURAL POLYMER-BASED NANOGEL FORMULATION FOR STIMULI-RESPONSIVE DELIVERY OF SORAFENIB TOSYLATE
30. DEVELOPMENT AND CHARACTERIZATION OF PENTAERYTHRITOL-EUDRAGIT®RS100 CO-PROCESSED EXCIPIENTS AS SOLID DISPERSION CARRIERS FOR ENHANCED AQUEOUS SOLUBILITY, IN VITRO DISSOLUTION, AND EX VIVO PERMEATION OF ATORVASTATIN
31. DEVELOPMENT AND ESTIMATION OF LIPOSOMES FOR THE TREATMENT OF CERVICAL CANCER
32. DEVELOPMENT AND EVALUATION OF CYCLOSPORINE-CURCUMIN LOADED NANOEMULGEL FOR MANAGEMENT OF RHEUMATOID ARTHRITIS
33. Development and evaluation of lysozyme loaded aquasome as a novel carrier for delivery of protein molecule dry powder inhaler
34. DEVELOPMENT AND EVALUATION OF NON-CONVENTIONAL DOSAGE FORM OF ANTI-FUNGAL WITH ANTIBIOTIC DRUG FOR THE TREATMENT OF MUCORMYCOSIS
35. Development and evaluation of palonosetron loaded fast dissolving drug delivery system for antiemetic activity
36. Development and Evaluation of Posaconazole Delayed Release Formulation by Hot Melt Extrusion using QbD Approach
37. DEVELOPMENT AND EVALUATION OF SYNBIOTIC MICROSPHERES USING INULIN AND LACTOBACILLUS PLANTARUM
38. Development and evaluation of taste masked formulation using hydrophobic polymers by hot melt extrusion technology
39. DEVELOPMENT AND EVALUATION OF TERBINAFINE HYDROCHLORIDE NIOSOMAL GEL
40. DEVELOPMENT AND EVALUATION OF THERMOSENSITIVE IN-SITU HYDROGEL COMPRISING OF IONIC LIQUID AND VITAMIN E FOR INTRANASAL ADMINISTRATION
41. DEVELOPMENT AND IN-VITRO EVALUATION OF MOLECULARLY IMPRINTED POLYMER FOR REMOVAL OF RESIDUAL ORGANO – PHOSPHEROUS PESTICIDE
42. DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPTLC METHOD FOR CERITINIB IN BULK AND MARKETED FORMULATION
43. DEVELOPMENT OF ANTIFUNGAL PHYTOSOMAL TOPICAL SPRAY CONTAINING MORINGA OLEIFERA LEAVES EXTRACT
44. DEVELOPMENT OF DRUG-LOADED NANOFIBER-BASED WOUND DRESSING
45. DEVELOPMENT OF MESOPOROUS SILICA NANOPARTICLES FOR CONTROLLED RELEASE OF BCS CLASS III DRUG
46. DEVELOPMENT OF NOVEL LIPID-BASED WATER DISPERSIBLE NANO DRUG DELIVERY SYSTEM FOR THE EFFECTIVE ORAL DELIVERY OF HYDROPHOBIC DRUGS
47. DEVELOPMENT OF TOPICAL FORMULATION OF APREMILAST FOR ENHANCED EFFICACY AND SAFETY
48. DEVELOPMENT OF TRI-LAYERED TABLET CONTAINING INCOMPITIBLE DRUGS USING PLATFORM TECHNOLOGY
49. DEVELOPMENT OF ZALEPLON-LOADED MESOPOROUS (MCM-41) SILICA NANOPARTICLES TO IMPROVE ORAL BIOAVAILABILITY
50. Development, Characterization and Cytotoxicity Assessment of Heparin Functionalized PEI-Liposomes as a Potential Carrier for the Treatment of Solid Tumor
51. DEVELOPMENT, CHARACTERIZATION AND HEPATOPROTECTIVE ACTIVITY EVALUATION OF QUERCETIN-LOADED PLURONIC® F127/CHITOSAN – MYRISTIC ACID MIXED MICELLES
52. DEVELOPMENT, OPTIMIZATION AND CHARACTRIZATION OF 4 MONTHS LURASIDONE HYDROCHLORIDE LOADED INTRADERMAL IN-SITU DEPOT FORMING FORMULATION
53. DEVLOPMENT OF TRANSDERMAL PATCH FOR HYPERTENSION MANAGEMENT BY A CALCIUM CHANNEL BLOCKER
54. DOUBLE-LOADED LIPOSOMES ENCAPSULATING UMBELLIFERONE IN HYDROXYPROPYL-β-CYCLODEXTRIN INCLUSION COMPLEXES: FORMULATION, CHARACTERIZATION, AND EVALUATION
55. DOXORUBICIN NANOSTRUCTURED LIPID CARRIERS FOR TREATMENT OF TRIPLE NEGATIVE BREAST CANCER
56. Dry Powder Inhalation of Mycobacteriophages in Pulmonary Tuberculosis
57. EFFECT OF EXCIPIENTS AND PROCESSING TECHNIQUES ON THE SOLUBILITY AND IN-VITRO DISSOLUTION RATE OF POORLY WATER-SOLUBLE DRUG: ITRACONAZOLE
58. EFFECT OF OXIDATION STATE ON OPTICAL PROPERTIES, DRUG LOADING AND HEMOCOMPATIBILITY OF GRAPHENE QUANTUM DOTS.
59. Enhancing glioblastoma treatment using functionalized hollow gold nanoparticles
60. EXPLORATION OF METHODOLOGICAL IMPLICATIONS ON DETERMINATION OF PERCENTAGE ENCAPSULATION EFFICIENCY OF LIPOSOMES
61. EXPLORATION OF NOVEL CURCUMIN-VANILLIC ACID EUTECTIC MIXTURE FORMULATIONS FOR IMPROVED PHYSICO-TECHNOLOGICAL PROPERTIES
62. EXPLORING NANOFORMULATION STRATEGY TO OVERCOME THE CHALLENGES OF RULED OUT MOLECULE
63. EXTRACELLULAR VESICLES FOR DRUG DELIVERY TO INNATE IMMUNE CELLS
64. FABRICATION AND CHARACTERIZATION OF PIRFENIDONE SCAFFOLD FOR WOUND HEALING
65. FABRICATION OF CHITOSAN NANOCOMPOSITES LOADED WITH BIOSYNTHETIC METALLIC NANOPARTICLES AND THEIR THERAPEUTIC INVESTIGATION
66. FABRICATION OF DOXYLAMINE/PYRIDOXINE LOADED TASTE MASKED MICROSPONGES FOR MANAGEMENT OF HYPEREMESIS GRAVIDARUM
67. Fabrication of Phospholipid Magnesomes containing Levosulpiride as an Intranasal Drug Delivery System for the Treatment of Schizophrenia
68. Fabrication, optimization and characterization of Candesartan cilexetil loaded mixed polymeric micelles for improving the anti-hypertensive activity.
69. FACILE TECHNOLOGY FOR EXTEMPORANEOUS PREPARATION OF LONG ACTING INJECTABLE MICROPARTICULATE SUSPENSION AT THE PATIENT SIDE
70. FORMULATION AND CHARACTERIZATION OF CLOZAPINE BUCCAL PATCH AS NOVEL DRUG DELIVERY FOR ANTIPSYCHOTIC DRUG
71. Formulation And Development of Binary and Ternary Inclusion Complexes of Ibrutinib for Solubility Enhancement
72. Formulation and development of Tinidazole colon-targeted beads and their incorporation in jelly-forming powder for improved pediatric compliance
73. FORMULATION AND EVALUATION OF COCRYSTALS OF RALOXIFENE HCL BEARING BIOENHANCERFOR SOLUBILITY AND BIOAVAILABILITY ENHANCEMENT
74. FORMULATION AND EVALUATION OF HERBAL ANTIACNE CREAM USING INDIAN BANYAN TREE ROOT EXTRACT

Posters to be presented on Day-2 (25th Feb 2023):

75. FORMULATION AND EVALUATION OF MOSQUITO REPELLENT CREAM PREPARED USING VITEX NEGUNDO LEAVES EXTRACT
76. FORMULATION AND EVALUATION OF MUCOADHESIVE PATCHES OF CILNIDIPINE FOR BUCCAL DRUG DELIVERY
77. Formulation and Evaluation of novel Proniosomal drug delivery system
78. FORMULATION AND EVALUATION OF PROMISING DRUG DELIVERY FOR ACNE.
79. Formulation and optimization of drug loaded nanoemulsions by Quality by Design approach
80. Formulation and Optimization of pyrazinamide loaded solid lipid nanoparticles for the treatment of tuberculosis
81. FORMULATION DEVELOPMENT AND EVALUATION OF TENELIGLIPTIN HYDROBROMIDE HYDRATE BUCCAL TABLET FOR THE TREATMENT OF TYPE -2 DIABETES MELLITUS
82. FORMULATION DEVELOPMENT AND EVALUATION OF TITANIUM DIOXIDE NANOPARTICLE AND ZINC OXIDE NANOPARTICLE LOADED TINTED SUNSCREEN FOR EFFECTIVE MANAGEMENT OF SUN BURN
83. FORMULATION, DEVELOPMENT AND IN VITRO EVALUATION OF IN SITU GEL OF PRAZOSIN HYDROCHLORIDE FOR NASAL ADMINISTRATION
84. FORMULATION, DEVLOPMENT AND CHARACTERIZATION OF NOVEL TOPICAL DELIVERY SYSTEM FOR OCULAR SURFACE DISEASE
85. HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF PACLITAXEL AND BAICALEIN: PHARMACEUTICAL AND PHARMACOKINETIC APPLICATIONS
86. IN SITU NANOEMULSIONS OF GLIMEPIRIDE – DESIGN AND EVALUATION
87. INFLUENCE OF CRYSTALLIZATION TECHNIQUES ON CRYSTAL HABIT AND PHARMACEUTICAL PERFORMANCE OF RIVAROXABAN
88. Influence of Gelucire on Dissolution rate enhancement of cholecalciferol using solid dispersion formulation
89. In-silico study for the screening of coformer in the formulation of cocrystals of Antilipidemic drug.
90. INTRANASAL DELIVERY OF CAROTENOID LOADED CATIONIC NANOPARTICLES FOR ALZHEIMERS THERAPY BY SUPPRESSION OF OXIDATIVE STRESS
91. INTRANASAL SERTRALINE NANOCRYSTALS: STATISTICAL OPTIMIZATION AND IN VIVO PHARMACOKINETICS AND PHARMACODYNAMICS STUDIES
92. INVESTIGATION OF IONIC LIQUIDS AS SOLUBILIZER AND TOPICAL PERMEATION ENHANCER FOR VITAMIN D3 CONTAINING MICELLAR GELS
93. INVESTIGATION OF KOLLIDON- SR FOR DEVELOPEMENT OF EPOSARTAN LOADED NANOFIBRE MAT BY ELECTROSPINNING TECHNIQUEA
94. Investigation of pH modulating thermosensitive in situ gel of Doxorubicin Hydrochloride and Photodynamic therapy for metronomic loco-regional therapy in breast cancer.
95. INVESTIGATION OF SPRAYABLE PHOTOACTIVE MULTIFUNCTIONAL NANOGEL OF BERBERINE HYDROCHLORIDE FOR ANTIBIOFILM ACTIVITY IN WOUND MANAGEMENT
96. INVESTIGATION OF THERMOSENSITIVE IN SITU GEL OF DOXORUBICIN HYDROCHLORIDE SPANLASTIC VESICLES AND ASPIRIN FOR METRONOMIC LOCO-REGIONAL THERAPY IN BREAST CANCER
97. IN-VITRO ASSESSMENT AND IMPACT OF DEVICE RESISTANCE OF DIFFERENT DRY POWDER INHALER DEVICES
98. LIPID POLYMER HYBRID NANOPARTICLE: DEVELOPMENT AND STATISTICAL OPTIMIZATION OF HMG-CoA REDUCTASE INHIBITOR FOR IMPROVED BIOAVAILABILITY
99. LOCALIZED DELIVERY OF INDOCYANINE GREEN AND GOLD NANOROD USING DISSOLVABLE MICRONEEDLE PATCH FOR ORAL CANCER PHOTOTHERAPY
100. MANAGEMENT OF PULMONARY HYPERTENSION BY DEVELOPING IMMEDIATE RELEASE FILM
101. Modelling of human skin microphysiological system for preclinical evaluation of drugs
102. MODIFIED POLYMERIC BASED MICROSPHERES AS A SMART APPROACH FOR ANTIPSYCHOTIC DRUG DELIVERY
103. MOLECULAR DYNAMICS SIMULATION: AN IN-SILICO APPROACH FOR DESIGNING SAFER AMPHOTERICIN B NANOFORMULATIONS
104. Moringa oleifera protein extracts (MOPE) nanoemulsion for water purification: Preformulation, formulation, characterization, and water treatment studies
105. MUCOADHESIVE FILMS FOR VULVOVAGINAL CANDIDIASIS: DEVELOPMENT & CHARACTERIZATION
106. Nano suspension of Tadalafil for the treatment of Erectile dysfunction
107. Nanostructured lipid carriers-based gel for enhanced topical delivery of Cyclosporine A
108. NOVEL COMBINATORIAL TOPICAL DRUG DELIVERY SYSTEM FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS
109. Olaparib and oxaliplatin combination@ human serum albumin nanoparticles inhibit tumor proliferation in triple-negative breast cancer mouse model
110. Peptide aptamer-functionalized stimuli-responsive nanocarriers for targeted delivery of anti-cancer drug to the breast cancer cells
111. PHARMACOKINETICS AND RED BLOOD CELL INTERACTION OF ARTEMETHER-LOADED POLYMERIC NANORODS PREPARED BY MECHANICAL STRETCHING
112. PHOSPHOLIPID-BASED NANO-SHUTTLES FOR ENHANCED DELIVERY OF FERULIC ACID
113. Polymeric Graphene Oxide Nanoparticles Loaded with Doxorubicin for Combined Photothermal and Chemotherapy in Triple Negative Breast Cancer
114. POROUS POLYMERIC VESICLES OF VITIS VINIFERA: FABRICATION AND EVALUATION
115. PRECLINICAL EVALUATION OF QUINAPYRAMINE SULPHATE-DOCUSATE SODIUM-LOADED SOLID LIPID NANOPARTICLES FOR ENHANCED TRYPANOCIDAL EFFECT AGAINST T. EVANSI
116. PRELIMINARY INVESTIGATIONS INTO DEVELOPMENT OF NANOFIBER MATS CONTAINING ANTI-VEGF AGENT FOR TREATMENT OF ORAL CANCER
117. PREPARATION AND EVALUATION OF AN ANXIOLYTIC NUTRACEUTICAL (GHRITA)
118. PREPARATION AND EVALUATION OF MOUTH DISSOLVING FILM OF ZINC SULPHATE MONOHYDRATE FOR MALNOURISHED CHILDREN
119. PREPARATION AND EVALUATION OF N-ACETYL CYSTEINE-LOADED THERMO-SENSITIVE HYDROGEL FOR INTRA-ARTICULAR ADMINISTRATION
120. Process optimization for preparation of curcumin and quercetin co-encapsulated lipid nanoparticles using microfluidic device.
121. Protein-vitamin nanoparticles for drug delivery in therapy-insensitive breast cancers
122. QUALITY BY DESIGN BASED DEVELOPMENT OF AZITHROMYCIN DIHYDRATE LOZENGES FOR THE TREATMENT OF BACTERIAL THROAT INFECTION
123. RICE BRAN EXTRACT-LOADED NANOEMULGEL: A PROMISING APPROACH IN TREATMENT OF ACNE
124. RILUZOLE LOADED SBA-15 MESOPOROUS SILICA NANOCARRIERS: IN-VITRO DISSOLUTION ENHANCEMENT
125. Self-Therapeutic Bicyclic Curcuminand for Cancer Therapy
126. SINGLE AND ‘COMBINATORIAL’ DRUG NANOCOMPOSITE-LOADED SUSTAINED DRUG DELIVERABLE CONTACT LENSES TO MANAGE MEAN DIURNAL INTRAOCULAR PRESSURE
127. SOLID LIPID NANOPARTICLES OF BETULIN WITH ANTIOXIDANT AND ANTICANCER ACTIVITY FOR TREATMENT OF BREAST CANCER, FORMULATION, CHARACTERIZATION AND IN-VITRO EVALUATION.
128. SOLUBILITY ENHANCEMENT OF EFONIDIPINE HYDROCHLORIDE ETHANOLATE BY SOLID DISPERSION USING HYDROPHILIC POLYMER
129. STIMULI-RESPONSIVE SELF-FOLDING FEEDSTOCK FOR PHARMACEUTICAL 4D PRINTING: A PARADIGM SHIFT
130. STUDY ON EFFECT OF ELLAGIC ACID ON POLYCYSTIC OVARIAN SYNDROME IN RATS
131. SUSTAINED DELIVERY OF C-PEPTIDE FROM BIOCOMPATIBLE POLYMERIC NANOPLEXES FOR TREATING DIABETIC COMPLICATIONS
132. Synbiotic enteric capsule loaded with mucoadhesive film of probiotic Lactobacillus acidophilus and prebiotic inulin to treat ulcerative colitis
133. SYNTHESIS AND ANTITUBERCULAR ACTIVITY OF PHENOL DERIVATIVES AS NOVEL ATP SYNTHASE INHIBITORS
134. Synthesis of a Bi-Functional Dendrimer-Mediated Nanocargoes Co-engineered with TPP and Sialic Acid for Efficient Brain Targeting and In vivo Pharmacokinetic
135. SYNTHESIS OF TEMOZOLOMIDE (TMZ) PERRILLYL ALCOHOL (POH) CARBAMATE LOADED HOLLOW GOLD NANOPARTICLES FOR THE TREATMENT OF TMZ RESISTANT GLIOMAS
136. Synthesis, Characterization and Evaluation of In-vitro Antibacterial activity of Pluronic F127 Coated Metal Oxide Nanoparticles
137. Tailoring Deep Eutectic Solvents to Provoke Solubility and Bioavailability of Naringin: Implication of Computational Approach
138. TARGETED POLYMERIC 3D INVERSE SUBSTRATES FOR EVALUATION OF CANCER CELL PROLIFERATION POTENTIAL INFLUENCED BY GROWTH PROMOTING/INHIBITING PEPTIDES AND ANTI-CANCER AGENTS
139. Temozolomide-lipoic acid conjugate as self-assembled nanomedicine for effective treatment of Glioblastoma Multiforme
140. TITLE:AN EMMERGING PLATFORM FOR CILNIDIPINE LOADED NANOSTRUCTURED LIPID CARRIER BASED DRUG DELIVERY SYSTEM FOR SOLUBILITY ENHANCEMENT
141. Topical delivery of biomacromolecule complexed nanoplexes: in vitro and ex vivo characterization
142. TOPICAL GRISEOFULVIN EMULGEL: DEVELOPMENT AND EVALUATION
143. TOPICAL ITRACONAZOLE LOADED LECIPLEX TO TREAT OPHTHALMIC FUNGAL INFECTION
144. Treptorelin-conjugated PAMAM dendrimers efficiently down regulate MCL-1 gene in vitro and in vivo for the treatment of breast and prostate cancer
145. Unique nanoparticulate drug delivery for targeting Fungal Infection
146. Fast Dissolving Granules– Technological Advancement in Oral Drug Delivery